Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine A Freije

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|June 12, 2025
Pan-viral ORFs discovery using massively parallel ribosome profilingShira Weingarten-Gabbay, Matthew R Bauer, Alexandra C Stanton, et al.
Science (New York, N.Y.)|April 15, 2017
Nucleic acid detection with CRISPR-Cas13a/C2c2Jonathan S Gootenberg, Omar O Abudayyeh, Jeong Wook Lee, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2Jon Arizti-Sanz, Catherine A Freije, Alexandra C Stanton, et al.
Nature|April 30, 2020
Massively multiplexed nucleic acid detection with Cas13Cheri M Ackerman, Cameron Myhrvold, Sri Gowtham Thakku, et al.
Science Advances|April 12, 2023
An RNA-based system to study hepatitis B virus replication and evaluate antiviralsYingpu Yu, William M Schneider, Maximilian A Kass, et al.
Medrxiv : the Preprint Server for Health Sciences|November 9, 2021
Equipment-free detection of SARS-CoV-2 and Variants of Concern using Cas13Jon Arizti-Sanz, A'Doriann Bradley, Yibin B Zhang, et al.
Science (New York, N.Y.)|April 28, 2018
Field-deployable viral diagnostics using CRISPR-Cas13Cameron Myhrvold, Catherine A Freije, Jonathan S Gootenberg, et al.
Nature Biomedical Engineering|May 31, 2022
Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variantsJon Arizti-Sanz, A'Doriann Bradley, Yibin B Zhang, et al.
Nature Communications|November 21, 2020
Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2Jon Arizti-Sanz, Catherine A Freije, Alexandra C Stanton, et al.
Plos Biology|September 24, 2024
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistJérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|June 12, 2025
Pan-viral ORFs discovery using massively parallel ribosome profilingShira Weingarten-Gabbay, Matthew R Bauer, Alexandra C Stanton, et al.
Science (New York, N.Y.)|April 15, 2017
Nucleic acid detection with CRISPR-Cas13a/C2c2Jonathan S Gootenberg, Omar O Abudayyeh, Jeong Wook Lee, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2Jon Arizti-Sanz, Catherine A Freije, Alexandra C Stanton, et al.
Nature|April 30, 2020
Massively multiplexed nucleic acid detection with Cas13Cheri M Ackerman, Cameron Myhrvold, Sri Gowtham Thakku, et al.
Science Advances|April 12, 2023
An RNA-based system to study hepatitis B virus replication and evaluate antiviralsYingpu Yu, William M Schneider, Maximilian A Kass, et al.
Medrxiv : the Preprint Server for Health Sciences|November 9, 2021
Equipment-free detection of SARS-CoV-2 and Variants of Concern using Cas13Jon Arizti-Sanz, A'Doriann Bradley, Yibin B Zhang, et al.
Science (New York, N.Y.)|April 28, 2018
Field-deployable viral diagnostics using CRISPR-Cas13Cameron Myhrvold, Catherine A Freije, Jonathan S Gootenberg, et al.
Nature Biomedical Engineering|May 31, 2022
Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variantsJon Arizti-Sanz, A'Doriann Bradley, Yibin B Zhang, et al.
Nature Communications|November 21, 2020
Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2Jon Arizti-Sanz, Catherine A Freije, Alexandra C Stanton, et al.
Plos Biology|September 24, 2024
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistJérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
Pageof 3